Literature DB >> 7639617

Tachykinin receptors and receptor subtypes.

R Patacchini1, C A Maggi.   

Abstract

The tachykinins, substance P, neurokinin A and neurokinin B, are a family of neuropeptides widely distributed in the mammalian central and peripheral nervous system. In the peripheral nervous system, tachykinins released from peripheral endings of sensory nerves are responsible for the neurogenic inflammation phenomenon. In the spinal cord/central nervous system, tachykinins play a role in pain transmission/perception and in some autonomic reflexes and behaviors. Their actions are mediated by three distinct receptors, termed NK1, NK2 and NK3. All tachykinin receptors belong to the superfamily of G protein-coupled receptors, with seven putative transmembrane spanning segments. In the past few years, a number of potent and selective antagonists, of both peptide and nonpeptide nature, has been developed for the NK1, NK2 and NK3 receptors. The contemporary isolation and cloning of the three tachykinin receptors enable now to study the molecular determinants for the interaction of natural tachykinins with their receptors, and the mechanism by which the antagonists interfere in this process. Furthermore, the introduction of tachykinin antagonists has revealed a striking species-related heterogeneity among the tachykinin receptors, and has also suggested a possible intra-species heterogeneity for both NK1 and NK2 receptors. However, molecular biology studies are needed to prove the existence of true tachykinin receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7639617

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  8 in total

1.  Substance P-induced cyclooxygenase-2 expression in human umbilical vein endothelial cells.

Authors:  Margherita Gallicchio; Arianna Carolina Rosa; Elisa Benetti; Massimo Collino; Chiara Dianzani; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Quantitative mass spectrometry analysis reveals that deletion of the TRPV1 receptor in mice alters substance P and neurokinin A expression in the central nervous system.

Authors:  Floriane Pailleux; Jérôme Lemoine; Francis Beaudry
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

3.  Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: implications for bone marrow metastasis.

Authors:  D Singh; D D Joshi; M Hameed; J Qian; P Gascón; P B Maloof; A Mosenthal; P Rameshwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

4.  The expression of neurokinin-1 and preprotachykinin-1 in breast cancer cells depends on the relative degree of invasive and metastatic potential.

Authors:  Tammy A Castro; Marion C Cohen; Pranela Rameshwar
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

5.  Detection of naturally expressed receptors for gastrin-releasing peptide and tachykinins using cyanine 3-labelled neuropeptides.

Authors:  N W Bunnett; D G Payan; E F Grady
Journal:  Histochem J       Date:  1996-11

6.  Capsaicin-induced mucus secretion in rat airways assessed in vivo and non-invasively by magnetic resonance imaging.

Authors:  H Karmouty-Quintana; C Cannet; R Sugar; J R Fozard; C P Page; N Beckmann
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

7.  Substance P increases neutrophil adhesion to human umbilical vein endothelial cells.

Authors:  Chiara Dianzani; Massimo Collino; Grazia Lombardi; Giovanni Garbarino; Roberto Fantozzi
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  An in vitro method to study the effects of hematopoietic regulators during immune and blood cell development.

Authors:  Nitixa Patel; Marianne Castillo; Pranela Rameshwar
Journal:  Biol Proced Online       Date:  2007-12-14       Impact factor: 3.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.